Get started
ORIENT PHARMA CO LTDOO

ORIENT PHARMA CO LTD

36.90TWDR
−0.05−0.14%
As of today at 03:01 GMT
TWD
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

4166 fundamentals

Key facts

Market capitalization‪8.00 B‬TWD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)79.35
Basic EPS (TTM)0.48TWD
Founded2008
Employees (FY)—
CEOChun-Tong Huang
Websiteoppharma.com
About

Orient Pharma Co., Ltd. engages in the research, development, and production of pharmaceutical products. Its products include anti-psychotics, drugs for treating Alzheimer's disease, psychostimulants, and drugs for treating Parkinson's disease. The company was founded on February 1, 2008 and is headquartered in Taipei, Taiwan.

Ownership
‪‪223.03 M‬‬
Free Float shares
‪‪115.13 M‬‬ (51.62%)
Closely held shares
‪‪107.91 M‬‬ (48.38%)
Free Float shares
‪‪115.13 M‬‬ (51.62%)
Closely held shares
‪‪107.91 M‬‬ (48.38%)
Capital structure
Market cap
‪‪8.00 B‬‬
Enterprise value
‪‪8.00 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪8.00 B‬‬
Price to earning ratio (P/E)
79.35x
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
79.35x
Price to sales ratio (P/S)
—
Valuation ratios
‪0.00‬
‪2.50‬
‪5.00‬
‪7.50‬
‪10.00‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪55.00‬
‪110.00‬
‪165.00‬
‪220.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−24%‬
‪−12%‬
‪0%‬
‪12%‬
‪24%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−210.00 M‬‬
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−210.00 M‬‬
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪160.00 M‬‬
‪‪320.00 M‬‬
‪‪480.00 M‬‬
‪‪640.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Factory Operations
Global Business
Medical Affairs
By country
Period: 2024
Taiwan
United States
Philippines
Other
China

Dividends

Dividend yield, history and sustainability

4166 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−250.00 M‬‬
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.